Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy

被引:0
作者
Goudarzi, Mohammad Taghi Hedayati [1 ]
Moradi, Maryam [2 ]
Abrotan, Saeed [1 ]
Saravi, Mehrdad [2 ]
Shirafkan, Hoda [3 ]
Irilouzadian, Rana [4 ]
Omran, Hossein Salehi [1 ]
机构
[1] Babol Univ Med Sci, Rohani Hosp, Sch Med, Dept Cardiol, Babol, Iran
[2] Babol Univ Med Sci, Fac Med, Dept Cardiol, Babol, Iran
[3] Babol Univ Med Sci, Hlth Res Inst, Social Determinants Hlth Res Ctr, Babol, Iran
[4] Iran Univ Med Sci, Burn Res Ctr, Tehran, Iran
关键词
SUDDEN-DEATH; TASK-FORCE; THERAPY; POPULATION; PREVENTION; EFFICACY; OUTCOMES; SOCIETY;
D O I
10.1155/2023/4552100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Hypertrophic cardiomyopathy (HCM) has different complications such as cardiac arrhythmia and sudden cardiac death (SCD). Insertion of an implantable cardioverter defibrillator (ICD) is recommended for HCM patients who are at high risk of SCD and malignant arrhythmias, despite having their own potential complications. Hypothesis. We aimed to investigate the prevalence of different complications of ICD insertion and the impact of the potential influential baseline characteristics in a one-year follow-up period. Methods. This was a retrospective study with a total of 71 HCM patients with ICD insertion. We evaluated the prevalence of different complications of ICD implantation and the impact of baseline characteristics on the occurrence of ICD complications using multivariate regression analysis in three 4-month periods. Results. In a one-year follow-up, 13 patients (18.3%) experienced at least one of the complications including pneumothorax, lead failure, ICD infection, inappropriate shocks, perforation, and upper limb deep vein thrombosis (DVT) with no mortality. Inappropriate shocks were reported as the most common (11.3%) complication during this period, with a gradual increase in the second (4.2%) and third (5.6%) follow-up sessions. Among all of the baseline characteristics that were investigated in this study, a positive history of hypertension was the only risk factor with significant impact on the occurrence of complications (P = 0.01). Conclusion. We demonstrated the occurrence of complications during a one-year follow-up as 18.3% in HCM patients with ICD insertion. A positive history of hypertension was the only baseline characteristic affecting the occurrence of complications, and inappropriate shocks were the most common complication.
引用
收藏
页数:7
相关论文
共 20 条
[11]   Hypertrophic Cardiomyopathy Present and Future, With Translation Into Contemporary Cardiovascular Medicine [J].
Maron, Barry J. ;
Ommen, Steve R. ;
Semsarian, Christopher ;
Spirito, Paolo ;
Olivotto, Iacopo ;
Maron, Martin S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (01) :83-99
[12]  
Maron BJ, 2000, CIRCULATION, V102, P858
[13]   Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. [J].
Maron, BJ ;
Shen, WK ;
Link, MS ;
Epstein, AE ;
Almquist, AK ;
Daubert, JP ;
Bardy, GH ;
Favale, S ;
Rea, RF ;
Boriani, G ;
Estes, NAM ;
Spirito, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (06) :365-373
[14]   PREVALENCE OF HYPERTROPHIC CARDIOMYOPATHY IN A GENERAL-POPULATION OF YOUNG-ADULTS - ECHOCARDIOGRAPHIC ANALYSIS OF 4111 SUBJECTS IN THE CARDIA STUDY [J].
MARON, BJ ;
GARDIN, JM ;
FLACK, JM ;
GIDDING, SS ;
KUROSAKI, TT ;
BILD, DE .
CIRCULATION, 1995, 92 (04) :785-789
[15]   Report of the 1995 World Health Organization International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies [J].
Richardson, P ;
McKenna, W ;
Bristow, M ;
Maisch, B ;
Mautner, B ;
OConnell, J ;
Olsen, E ;
Thiene, G ;
Goodwin, J ;
Gyarfas, I ;
Martin, I ;
Nordet, P .
CIRCULATION, 1996, 93 (05) :841-842
[16]   Outcome and Complications After Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy Systematic Review and Meta-Analysis [J].
Schinkel, Arend F. L. ;
Vriesendorp, Pieter A. ;
Sijbrands, Eric J. G. ;
Jordaens, Luc J. L. M. ;
ten Cate, Folkert J. ;
Michels, Michelle .
CIRCULATION-HEART FAILURE, 2012, 5 (05) :552-559
[17]   DISTRIBUTION OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTROPHIC CARDIOMYOPATHY - A TWO-DIMENSIONAL ECHOCARDIOGRAPHIC STUDY [J].
SHAPIRO, LM ;
MCKENNA, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 2 (03) :437-444
[18]   Implantable Cardioverter-Defibrillator in PatientsWith Hypertrophic Cardiomyopathy: Efficacy and Complications of the Therapy in Long-Term Follow-up [J].
Syska, Pawel ;
Przybylski, Andrzej ;
Chojnowska, Lidia ;
Lewandowski, Michal ;
Sterlinski, Maciej ;
Maciag, Aleksander ;
Gepner, Katarzyna ;
Pytkowski, Mariusz ;
Kowalik, Ilona ;
Maczynska-Mazuruk, Renata ;
Ruzyllo, Witold ;
Szwed, Hanna .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2010, 21 (08) :883-889
[19]   Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications [J].
Vriesendorp, Pieter A. ;
Schinkel, Arend F. L. ;
Van Cleemput, Johan ;
Willems, Rik ;
Jordaens, Luc J. L. M. ;
Theuns, Dominic A. M. J. ;
van Slegtenhorst, Marjon A. ;
de Ravel, Thomy J. ;
ten Cate, Folkert J. ;
Michels, Michelle .
AMERICAN HEART JOURNAL, 2013, 166 (03) :496-502
[20]   Implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: an updated systematic review and meta-analysis of outcomes and complications [J].
Wang, Nelson ;
Xie, Ashleigh ;
Tjahjono, Richard ;
Tian, David H. ;
Phan, Steven ;
Yan, Tristan D. ;
Bajona, Pietro ;
Phan, Kevin .
ANNALS OF CARDIOTHORACIC SURGERY, 2017, 6 (04) :298-306